Jim Tananbaum

Founder at Foresite Capital Management LLC

Jim Tananbaum

Jim Tananbaum

Founder at Foresite Capital Management LLC

Overview
Career Highlights

Foresite Capital Management LLC
Infinity Discovery, Inc.
Prospect Venture Partners

RelSci Relationships

3874

Number of Boards

32

Birthday

05/1963

Age

56

Number of Awards

1

Contact Data
Trying to get in touch with Jim Tananbaum? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jim Tananbaum likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Mindstrong Health

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at Shaklee Global Group, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Managing Director at Foresite Capital Management LLC

Relationship likelihood: Strong

Partner at Foresite Capital Management LLC

Relationship likelihood: Strong

General Counsel at Foresite Capital Management LLC

Relationship likelihood: Strong

Managing Director at Foresite Capital Management LLC

Relationship likelihood: Strong

Partner at Foresite Capital Management LLC

Relationship likelihood: Strong

Managing Director at Foresite Capital Management LLC

Relationship likelihood: Strong

Founder, President & Chief Executive Officer at Orbus Therapeutics, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Decibel Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Jim Tananbaum
Potential Connections via
Relationship Science
You
Jim Tananbaum
Founder at Foresite Capital Management LLC
Education
BS

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

MBA

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

MD

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Memberships
Member
Current

YPO (Young Presidents’ Organization) connects people with successful young chief executives in a global network unlike any other. Founded in 1950 in New York City by a young president named Ray Hickok, the organization unites approximately 20,000 business leaders in more than 120 countries around a shared mission: Better Leaders Through Education and Idea Exchange. A great deal has changed since YPO’s founding but certain things have remained the same: the value of a peer network and trusted mentors, the importance of ongoing education, and the need for a “safe haven” where issues can be aired in an environment of confidentiality. Over the past six decades, YPO has maintained its core commitment to these ideals while embracing change with each successive generation of young business leaders.

Career History
General Partner
1993 - 1997

Sierra Ventures focuses on investments in a variety of technology companies including those involved in enterprise software, Internet and web applications, software-as-a-service, security, mobile applications, telecommunications, semiconductors, hardware systems, components and subsystems, storage and energy. The firm invests in companies located in North America, Europe, China and India. Two-thirds of their investments are in companies located outside of the San Francisco Bay Area. Sierra Ventures invests across all stages of the lifecycle from seed to growth. Initial investments typically range from $2 million to $25 million, with as much as $3 million to $35 million invested over the life of a company. Sierra Ventures also makes select seed-stage investments of $500,000 to $2 million.

Senior Manager-Product
1991 - 1993

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Co-Founder
2000 - 2010

Prospect Venture Partners focuses on investments in commercially attractive biomedical technology and life science companies that have management teams, proprietary products and innovative technology or services. They participate in new company incubations,seed, first and second venture financing rounds and expansion capital financings of later-stage private and public companies with proven business models. Initial investments range from $500,000 to $10 million with $10 million to $20 million invested over the life of a company. Prospect Venture Partners will serve as a lead investor or as a co-lead in a syndicate. The firm typically takes a seat on the boards of their portfolio companies.

Boards & Committees
Director
2019 - Current

Healthverity, Inc. engages in developing technologies and software tools to discover and integrate patient data set. The company was founded by Andrew Goldberg and Andrew Kress in 2014 and is headquartered in Philadelphia, PA.

Director
2013 - Current

Sequenta, Inc. operates as a biotech company which discovers and develops clinical diagnostics based on immune system status. It develops molecular diagnostic assays based on a sequencing approach to the profiling of T and B cell receptor repertoires. The firm also provides sequencing-based test for minimal residual disease for leukemia and lymphoma. The company was founded by Thomas D. Willis and Malek Faham in 2007 and is headquartered in South San Francisco, CA.

Director
2003 - Current

Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA.

Member, University Council
Current

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

Director
Current

The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders of society to shape global, regional and industry agendas.

Member, Board of Trustees
Prior

Fine Arts Museums of San Francisco owns and operates museums. Its collections include European painting, sculpture, and decorative arts. The company is headquartered in San Francisco. CA.

Political Donations
$1,000
2011

Senator from Virginia

$1,071
2009
$937
2007
Transactions
Details Hidden

Foresite Capital Fund II LP raised money in a private placement transaction

Details Hidden

Foresite Capital IV-C LLC raised money in a private placement transaction

Details Hidden

ForeSite Capital II-AA LLC raised money in a private placement transaction

Investments
Details Hidden

GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA.

Details Hidden

Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include Xyrem, Erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.

Details Hidden

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.

Awards & Honors
Rank #80
2015
Forbes Magazine - The Midas List
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jim Tananbaum. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jim Tananbaum's profile does not indicate a business or promotional relationship of any kind between RelSci and Jim Tananbaum.